• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Recent Advances in the Study of 8-Fluoro-5-methoxy-Quinoline (CAS: 887769-93-9) in Chemical Biology and Pharmaceutical Research

The compound 8-fluoro-5-methoxy-Quinoline (CAS: 887769-93-9) has recently emerged as a significant focus in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This quinoline derivative, characterized by the presence of a fluorine atom at the 8-position and a methoxy group at the 5-position, exhibits notable biological activity, making it a promising candidate for drug development. Recent studies have explored its role in modulating various biological pathways, including its interactions with enzymes and receptors involved in inflammatory and oncogenic processes.

One of the key areas of investigation has been the synthesis and optimization of 8-fluoro-5-methoxy-Quinoline derivatives to enhance their pharmacokinetic and pharmacodynamic properties. Researchers have employed advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, to introduce diverse functional groups to the quinoline core. These modifications have led to the discovery of compounds with improved selectivity and potency against specific biological targets, such as protein kinases and G-protein-coupled receptors (GPCRs).

In a recent study published in the Journal of Medicinal Chemistry, a series of 8-fluoro-5-methoxy-Quinoline analogs were evaluated for their inhibitory effects on a panel of cancer-related kinases. The results demonstrated that certain derivatives exhibited nanomolar IC50 values against key kinases involved in tumor proliferation and metastasis. Molecular docking studies further revealed that the fluorine and methoxy substituents played a critical role in stabilizing the ligand-receptor interactions, highlighting the importance of these functional groups in drug design.

Another significant development involves the application of 8-fluoro-5-methoxy-Quinoline in the treatment of neurodegenerative diseases. Preclinical studies have shown that this compound can cross the blood-brain barrier and modulate the activity of neurotransmitter systems implicated in Alzheimer's and Parkinson's diseases. For instance, a recent in vivo study reported that 8-fluoro-5-methoxy-Quinoline derivatives reduced amyloid-beta plaque formation and improved cognitive function in transgenic mouse models of Alzheimer's disease.

Despite these promising findings, challenges remain in the clinical translation of 8-fluoro-5-methoxy-Quinoline-based therapeutics. Issues such as metabolic stability, potential off-target effects, and formulation optimization need to be addressed in future research. Nevertheless, the growing body of evidence underscores the potential of this compound as a versatile scaffold for the development of novel drugs targeting a wide range of diseases.

In conclusion, 8-fluoro-5-methoxy-Quinoline (CAS: 887769-93-9) represents a valuable tool in chemical biology and pharmaceutical research. Its unique structural features and diverse biological activities make it an attractive candidate for further investigation. Continued efforts in synthetic chemistry, target identification, and preclinical evaluation will be essential to unlock its full therapeutic potential.

• 63010-71-9(8-fluoroquinolin-4-ol)
• 209353-21-9(8-Fluoro-6-methoxyquinoline)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)